Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems Recombinant Protein;Biotinylated Human VEGF165, epitope tag free, ultra sensitivity (primary amine labeling);HEK293;25UG;VE5,RP1-261G23.1,MGC70609,MVCD1,MVCD-1,VEGF 165,VEGF-A,VEGFA,VPF,VEGF165,VEGF-165,VEGF121,VEGF120,VEGF186,VEGF164,VEGF110

Supplier:  ACROBiosystems VE5H821025UG

Encompass_Preferred

Recombinant Protein;Biotinylated Human VEGF165, epitope tag free, ultra sensitivity (primary amine labeling);25UG;MABSol Biotinylated Human VEGF165 (VE5-H8210) is expressed from human HEK293 cells. It contains AA Ala 27 - Arg 191 (Accession # NP_001165097). It is the biotinylated form of ActiveMax Recombinant Human VEGF165 (Cat # VE5-H4210).;The product does NOT contain any epitope tags. The protein has a calculated MW of 19 kDa (monomer). The protein migrates as 24 kDa (monomer) on a SDS-PAGE gel under reducing (R) condition due to glycosylation and 43-50 kDa under non-reducing (NR) condition.;Immobilized human VEGFR1/R2, Fc tag at 2g/mL (100 L/well) can bind Biotinylated Human VEGF (Cat. No. VE5-H8210) with a linear range of 0.39-3.1 ng/mL (QC tested).;Immobilized Human Neuropilin-1, His Tag (Cat.No. NR1-H5228) at 2 g/mL (100 L/well) can bind Biotinylated Human VEGF165 (Cat.No. VE5-H8210) with a linear range of 5-40 ng/mL (Routinely tested).

Catalog No. NC0862091


Add to Cart

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit